Status: Recruiting
Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.
The goal of this study is to collect clinical data and samples and to evaluate the feasibility of allogeneic hematopoietic cell transplantation (HCT) in children and young adults with refractory Systemic Juvenile Idiopathic Arthritis (sJIA), including those with sJIA-associated lung disease (sJIA-LD).
Participants needed: 20
Trial details
Age: Up to 35Biological sex: AllType: ObservationalSponsor: Children's Hospital Medical Center, CincinnatiUpdated: Sep 29, 2026Locations: 1
Eligibility criteria
Diagnosis: Systemic Juvenile Idiopathic Arthritis (sJIA) diagnosed prior to age... [+3]
Uncontrolled Infection: Presence of a severe, uncontrolled infection at time of... [+4]